Chondrocyte Implantation

A Prospective, Randomized, Open-Label, Multicenter, Phase III Noninferiority Trial to Compare the Clinical Efficacy of Matrix-Associated Autologous Chondrocyte Implantation With Spheroid Technology Versus Arthroscopic Microfracture for Cartilage Defects of the Knee [10.1177/2325967119854442]

Explore More

Tailoring the Mechanical Properties of Tissue Engineering Scaffolds made from Decellularized Cartilage [10.5075/EPFL-THESIS-9059]

Explore More

Prähabilitation und Rehabilitation nach knorpelregenerativen Eingriffen [10.1007/s00142-019-0266-6]

Explore More

Preoperative Validation of the Patient-Reported Outcomes Measurement Information System (PROMIS) in Patients With Articular Cartilage Defects of the Knee. [10.1016/j.arthro.2019.08.043]

Explore More

Clinical outcome and success rates of ACI for cartilage defects of the patella: a subgroup analysis from a controlled randomized clinical phase II trial (CODIS study) [10.1007/s00402-019-03264-x]

Explore More

Emerging Technologies in Cartilage Restoration [10.1007/978-3-030-01491-9_18]

Explore More

Tissue Engineering for the Cartilage Repair of the Ankle [10.1007/978-3-662-58704-1_10]

Explore More

Matrix-Induced Autologous Chondrocyte Implantation With Autologous Bone Grafting for Osteochondral Lesions of the Femoral Trochlea [10.1016/j.eats.2018.10.022]

Explore More

Survival Rates of Various Autologous Chondrocyte Grafts and Concomitant Procedures. A Prospective Single-Center Study over 18 Years [10.1177/0963689719861922]

Explore More

Editorial Commentary: Trends in Cartilage Surgery-Who Is Steering the Ship? [10.1016/j.arthro.2018.10.007]

Explore More